Placental growth factor: What hematologists need to know

Area of Science:

• Hematology
• Vascular Biology
• Molecular Medicine

Background:

• Placental growth factor (PlGF) is an angiogenic factor initially identified in the placenta.
• PlGF expression is also observed in ischemic or damaged tissues.
• Emerging research highlights PlGF's involvement in the pathobiology of various blood diseases.

Purpose of the Study:

• To review recent studies on the potential role of PlGF in blood disorders.
• To explore PlGF's significance in hemoglobinopathies and hematologic malignancies.
• To suggest future research directions for PlGF in hematology.

Main Methods:

• Literature review of recent studies on PlGF and blood disorders.
• Analysis of research investigating PlGF in sickle cell disease, leukemias, and transplantation complications.
• Synthesis of current knowledge regarding PlGF's pathobiological relevance.

Main Results:

• PlGF is implicated in the pathobiology of blood diseases, including hemoglobinopathies and hematologic malignancies.
• Ongoing investigations explore PlGF's role in specific conditions like sickle cell disease and leukemias.
• PlGF is relevant to complications associated with hematopoietic cell transplantation.

Conclusions:

• PlGF is a significant factor in the pathobiology of blood disorders.
• Further research into PlGF's role may lead to novel therapeutic strategies.
• Targeting PlGF presents a potential avenue for treating blood diseases and transplantation complications.